CAIROLI ROBERTO

Travi, G., Peracchi, F., Merli, M., Ravano, E., Frustaci, A., Deodato, M., et al. (2025). Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection. INFECTIOUS DISEASE REPORTS, 17(2) [10.3390/idr17020017]. Dettaglio

Polverelli, N., Zerbi, C., Benevento, M., Algeri, M., Algarotti, A., Angelucci, E., et al. (2025). Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study. AMERICAN JOURNAL OF HEMATOLOGY [10.1002/ajh.70145]. Dettaglio

Cairoli, R., Del Castello, L., Imbergamo, S., Pierdomenico, E., Papayannidis, C., Borlenghi, E., et al. (2025). Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience. CANCER, 131(17) [10.1002/cncr.70055]. Dettaglio

Trojani, A., Pungolino, E., Di Camillo, B., Bossi, L., Palumbo, C., D'Adda, M., et al. (2025). Bone Marrow CD34+/lin− Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) After 12 Months of Nilotinib Treatment Exhibit a Different Gene Expression Signature Compared to the Diagnosis and the Corresponding Cells from Healthy Subjects. CANCERS, 17(6) [10.3390/cancers17061022]. Dettaglio

Frustaci, A., Zappaterra, A., Turri, G., Rossi, V., Deodato, M., Gambacorti‐passerini, C., et al. (2025). Pirtobrutinib is an Effective Salvage Treatment After Ibrutinib in Bing–Neel Syndrome. AMERICAN JOURNAL OF HEMATOLOGY, 100(10), 1878-1881 [10.1002/ajh.27759]. Dettaglio